Investing Profile

Sarah Bhagat

InvestorVC
General Partner at Sofinnova Investments
sofinnova.com/team/sarah-bhag...Menlo Park, California
Photo of Sarah Bhagat, General Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Yale University Network
366 CONNECTIONS
Stanford University Network
364 CONNECTIONS
Stanford Center for Clinical Research (SCCR) Network
50 CONNECTIONS
Massachusetts General Hospital Network
40 CONNECTIONS
Canaan Network
34 CONNECTIONS
cb
Sofinnova Investments General Partner
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Atsena Therapeutics
Series ADec 2020$55M
$210M
Co-investors: Jacqueline Grant (Abingworth), Jason Lettmann (Morgenthaler Ventures)
Inozyme
Series AApr 2019$67M
$67M
Co-investors: Rob Hopfner (Pivotal Life Sciences)
Clinical Research Coordinator Massachusetts General HospitalPresent
Research Assistant The Rockefeller UniversityPresent
Venture Fellow CanaanPresent
Venture Fellow Canaan PartnersPresent
Postdoctoral Fellow Stanford UniversityPresent
Board Observer NextCure, Inc.Present
Board Observer Antiva Biosciences, Inc.Present
Board Observer YmAbsPresent
Board Observer Neurana PharmaceuticalsPresent
Board Observer AkouosPresent
Board Member Inozyme PharmaPresent
Neuroscience: Translate Oversight Committee Stanford Center for Clinical Research (SCCR)Present
Neuroscience: Translate Oversight Committee Stanford University School of MedicinePresent
Board Member Aeovian PharmaceuticalsPresent
Board Member PromediorPresent
Board Observer NorthSea TherapeuticsPresent
Chairperson Atsena TherapeuticsPresent
Advisor Atsena TherapeuticsPresent
Biotech Advisor The Rockefeller UniversityPresent
Biotech Advisor MultiplePresent
General Partner Sofinnova InvestmentsPresent
Franklin & Marshall College BA Biological Psychology; Classics
Yale University Master’s Degree Neuroscience
Sign in with Google →
Sign in with Google →